perospirone
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Nov 25, 2020 (NCT04826510)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Serotonin 2a (5-HT2a) receptorANTAGONIST
HTR2A antagonist
Chemistry & pharmacology
Loading structure…
SMILES
O=C1[C@H]2CCCC[C@H]2C(=O)N1CCCCN1CCN(c2nsc3ccccc23)CC1- Mol. weight
- 426.59 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1472975 ↗
Also known as
- lullan
- perospirone
- perospirone
- perospirone
- perospirone
- perospirone
- perospirone
- perospirone
- perospirone hcl
- perospirone hydrochloride
- perospirone hydrochloride dihydrate
- perospirone hydrochloride hydrate
- sm 9018
- sm-9018
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04826510 | Phase 4 | Nov 25, 2020 | Jiao Tong University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiao Tong University | Academic/Hospital | 1 | 1 | 1 | 2020 |
1 organizations
Page 1 / 1